Logo image of DLPN

DOLPHIN ENTERTAINMENT INC (DLPN) Stock Fundamental Analysis

NASDAQ:DLPN - Nasdaq - US25686H3084 - Common Stock - Currency: USD

1.15  +0.05 (+4.55%)

After market: 1.08 -0.07 (-6.09%)

Fundamental Rating

2

DLPN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 72 industry peers in the Entertainment industry. Both the profitability and financial health of DLPN have multiple concerns. DLPN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DLPN had negative earnings in the past year.
In the past year DLPN has reported a negative cash flow from operations.
DLPN had negative earnings in each of the past 5 years.
In the past 5 years DLPN always reported negative operating cash flow.
DLPN Yearly Net Income VS EBIT VS OCF VS FCFDLPN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M

1.2 Ratios

DLPN's Return On Assets of -24.93% is on the low side compared to the rest of the industry. DLPN is outperformed by 79.17% of its industry peers.
Looking at the Return On Equity, with a value of -156.77%, DLPN is doing worse than 76.39% of the companies in the same industry.
Industry RankSector Rank
ROA -24.93%
ROE -156.77%
ROIC N/A
ROA(3y)-21.58%
ROA(5y)-16.18%
ROE(3y)-81.5%
ROE(5y)-56.51%
ROIC(3y)N/A
ROIC(5y)N/A
DLPN Yearly ROA, ROE, ROICDLPN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

The Gross Margin of DLPN (97.34%) is better than 98.61% of its industry peers.
In the last couple of years the Gross Margin of DLPN has grown nicely.
The Profit Margin and Operating Margin are not available for DLPN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 97.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y3%
DLPN Yearly Profit, Operating, Gross MarginsDLPN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

0

2. Health

2.1 Basic Checks

DLPN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DLPN has been increased compared to 1 year ago.
Compared to 5 years ago, DLPN has more shares outstanding
DLPN has a worse debt/assets ratio than last year.
DLPN Yearly Shares OutstandingDLPN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
DLPN Yearly Total Debt VS Total AssetsDLPN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -2.94, we must say that DLPN is in the distress zone and has some risk of bankruptcy.
DLPN has a worse Altman-Z score (-2.94) than 80.56% of its industry peers.
DLPN has a Debt/Equity ratio of 1.89. This is a high value indicating a heavy dependency on external financing.
DLPN has a worse Debt to Equity ratio (1.89) than 72.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.89
Debt/FCF N/A
Altman-Z -2.94
ROIC/WACCN/A
WACC8.64%
DLPN Yearly LT Debt VS Equity VS FCFDLPN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

DLPN has a Current Ratio of 0.74. This is a bad value and indicates that DLPN is not financially healthy enough and could expect problems in meeting its short term obligations.
DLPN has a worse Current ratio (0.74) than 62.50% of its industry peers.
A Quick Ratio of 0.74 indicates that DLPN may have some problems paying its short term obligations.
With a Quick ratio value of 0.74, DLPN perfoms like the industry average, outperforming 40.28% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.74
DLPN Yearly Current Assets VS Current LiabilitesDLPN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

5

3. Growth

3.1 Past

DLPN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.95%, which is quite impressive.
Looking at the last year, DLPN shows a small growth in Revenue. The Revenue has grown by 0.32% in the last year.
DLPN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.63% yearly.
EPS 1Y (TTM)41.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-400%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y13.1%
Revenue growth 5Y15.63%
Sales Q2Q%-20.12%

3.2 Future

Based on estimates for the next years, DLPN will show a very strong growth in Earnings Per Share. The EPS will grow by 55.75% on average per year.
Based on estimates for the next years, DLPN will show a quite strong growth in Revenue. The Revenue will grow by 11.32% on average per year.
EPS Next Y95.05%
EPS Next 2Y55.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.92%
Revenue Next 2Y11.32%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DLPN Yearly Revenue VS EstimatesDLPN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
DLPN Yearly EPS VS EstimatesDLPN Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4 6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DLPN. In the last year negative earnings were reported.
DLPN is valuated cheaply with a Price/Forward Earnings ratio of 2.62.
100.00% of the companies in the same industry are more expensive than DLPN, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.60. DLPN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 2.62
DLPN Price Earnings VS Forward Price EarningsDLPN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DLPN Per share dataDLPN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DLPN's earnings are expected to grow with 55.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.75%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DLPN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DOLPHIN ENTERTAINMENT INC

NASDAQ:DLPN (6/30/2025, 8:01:00 PM)

After market: 1.08 -0.07 (-6.09%)

1.15

+0.05 (+4.55%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-12 2025-08-12/amc
Inst Owners4.16%
Inst Owner Change-51.71%
Ins Owners23.8%
Ins Owner Change3.5%
Market Cap12.85M
Analysts82.86
Price Target5.1 (343.48%)
Short Float %0.63%
Short Ratio1.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-38.89%
Min EPS beat(2)-47.06%
Max EPS beat(2)-30.72%
EPS beat(4)1
Avg EPS beat(4)-157.9%
Min EPS beat(4)-566.67%
Max EPS beat(4)12.85%
EPS beat(8)2
Avg EPS beat(8)-320.21%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)9.56%
Min Revenue beat(2)-0.19%
Max Revenue beat(2)19.31%
Revenue beat(4)3
Avg Revenue beat(4)11.09%
Min Revenue beat(4)-0.19%
Max Revenue beat(4)19.31%
Revenue beat(8)5
Avg Revenue beat(8)7.09%
Revenue beat(12)6
Avg Revenue beat(12)4.03%
Revenue beat(16)8
Avg Revenue beat(16)3.7%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)83.33%
EPS NY rev (1m)54.55%
EPS NY rev (3m)-141.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)3.85%
Revenue NY rev (3m)-2.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.62
P/S 0.26
P/FCF N/A
P/OCF N/A
P/B 1.38
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.19
EYN/A
EPS(NY)0.44
Fwd EY38.14%
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS4.35
BVpS0.83
TBVpS-2.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.93%
ROE -156.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 97.34%
FCFM N/A
ROA(3y)-21.58%
ROA(5y)-16.18%
ROE(3y)-81.5%
ROE(5y)-56.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y3%
F-Score4
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 1.89
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.74
Quick Ratio 0.74
Altman-Z -2.94
F-Score4
WACC8.64%
ROIC/WACCN/A
Cap/Depr(3y)1.78%
Cap/Depr(5y)1.86%
Cap/Sales(3y)0.08%
Cap/Sales(5y)0.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-400%
EPS Next Y95.05%
EPS Next 2Y55.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.32%
Revenue growth 3Y13.1%
Revenue growth 5Y15.63%
Sales Q2Q%-20.12%
Revenue Next Year4.92%
Revenue Next 2Y11.32%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year131.42%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y86.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y86%
OCF growth 3YN/A
OCF growth 5YN/A